AI RAPNO releases a blueprint @TheLancetOncol to accelerate clinically reliable AI for pediatric brain tumor imaging. Grateful to work with @anahita_fathi in partnership with global leaders in AI and neuro-oncology @BenjaminKannMD @fangusaro @PennRadiology

And that's a wrap to my first Academy meeting #AAcNS, where I had the privilege to present our work, learn about cutting edge science, catch up with friends, while also taking in the amazing sights in Athens with family! Thanks to Dr. Cockroft for the sponsorship #Greece

Neuro-Oncology No-STOP: From EANO in Prague to ESMO in Berlin @EANOassociation @myESMO

🚨 Big news from #EANO2025! Final #CATNON results show adding 12 cycles of temozolomide after radiotherapy doubles survival in IDH-mutant anaplastic astrocytoma: 12.5 vs 6 years. A global academic effort in rare cancers. 🔗Full story: https://t.co/b0YtBpHeEk @EANOassociation

It was a wonderful moment today to announce that I will be the local chair of the @EANOassociation 2026 meeting in the beautiful Rome. I look forward to working on this and see you all there

Dr. Sheehan highlighted growth of JNO and announced launch of Journal of Neuro-Oncology: Discovery, led by Editor-in-Chief Dr. Hadjipanayis. JNOD will expand opportunities for high-quality publications and further serve global neuro-oncology community. https://t.co/mB2kWBO1Fh

📢🔥Hot Off the @NeuroOnc Press🔥📢 @jana_ivanidze et al. DOTATATE PET/MRI improves on MRI alone to confirm complete removal of WHO Grade 2 Meningioma ! How can we use this to better guide future therapy? More importantly, can this information give our patients greater peace of

🚨 Just published in @NeuroOnc #advances - thankful to our multidisciplinary team & study participants DOTATATE PET-confirmed GTR predicts long-term PFS in WHO2 #meningioma 📖 https://t.co/fOfZSDG4hi #NeuroOncology #BrainTumor #PETMRI #Theranostics @WCMRadiology @WeillCornell

A big thank you to Dr. Norbert Galldiks, friend and collaborator, and world leader in neuro-oncologic imaging, for his inspiring lecture on amino acid PET at our Neuroradiology Speaker Series. Grateful for the insights and continued partnership! @galldiks @PennRadiology

Just launched: Neuro-Oncology Pediatrics! A new open-access journal dedicated to advancing care & research for children and AYAs with brain & nervous system tumors. Published by Oxford University Press and co-owned by EANO and SNO. https://t.co/ytwF2DrF9w

Great to see this comprehensive review on: current challenges and future directions for researchGlioblastoma in Adults: A @NeuroOnc and @EANOassociation Consensus Review on Current Management and Future Directions https://t.co/kMt7GXfQhh @SapienzaRoma

But let's not forget, there is more to cognition than just hippocampus. This was noted in our recent review on radiosurgery for brain mets:

Our #NeuroPET consensus statement is now out in @TheAJNR! 🎉 Amazing collaboration across disciplines and continents. Thanks to our entire team, especially @LabBarajas 💪 and to @TheASNR leadership for their support. https://t.co/h0nm3GrQIH @WCMRadiology @OHSUKnight

Beyond thrilled to see our @TheASNR #NeuroPET consensus statement published in @TheAJNR! What an honor to be part of such a thoughtful and visionary team. Proud of what we accomplished together @jana_ivanidze! Lots more will be coming from this initiative, stay tuned!

I am honoured to be leading this Italian, academic trial for patients with meningioma! Thanks to all the Centers involved in this study and neuro-oncology team at Istituto Oncologico Veneto IOV - IRCCS #meningioma #regorafenib @martapdn @AIOMtweet https://t.co/RnLvwlXOj3

Servier Receives Positive CHMP Opinion for VORANIGO® (vorasidenib) for the Treatment of Adults and Adolescents with Grade 2 IDH-mutant Diffuse Glioma https://t.co/NSaYkpUmzm

Thank you, Norbert, for your leadership in driving this important work forward! I was honored to contribute to the RANO group's updated guideline on PET imaging in glioma patients. Great team effort! @galldiks @PennRadiology

🧠 👉New clinical practice guideline in The Lancet Oncology. Out of the RANO group, we are proud to present our updated multidisciplinary, evidence-based guideline on PET imaging in patients with glioma. https://t.co/rIe4t8leR0 🔗 #NeuroOncology #PETimaging #Glioma #RANO

Check out the latest update on the use of PET for gliomas from the RANO working group and EANO. PET is extremely helpful for our glioma patients identifying tumor otherwise not seen on MRI and helpful in response assessment. @TheLancetOncol https://t.co/QFCyOA71VN

Here new recommendations for the use of PET imaging in patients with gliomas from RANO working group and the @EANOassociation Update to the RANO working group and EANO recommendations for the clin... https://t.co/a73x5vIXpC @SapienzaRoma @galldiks